Orally available pharmaceutical formulation suitable for improved management of movement disorders

The present invention provides a pharmaceutical formulation for oral administration comprising an agonist of two or more of the 5-HT1B, 5-HT1D and 5-HT1F receptors, such as a triptan, e.g. zolmitriptan, in a matrix constituent with extended release characteristics, and further comprising a 5-HT1A-R...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Kreilgaard, Mads, Mikkelsen, Jens D, Thomsen, Mikael S, Nielsen, Peter Gudmund, Hansen, John Bondo
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!